Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Masieri

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Investigational Allergology & Clinical Immunology|December 5, 2017
Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe AsthmaB Sposato, M Scalese, M Milanese, et al.
European Journal of Internal Medicine|February 4, 2018
Factors reducing omalizumab response in severe asthmaB Sposato, M Scalese, M Milanese, et al.
Respiratory Medicine and Research|October 11, 2020
Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposisB Sposato, M Scalese, G Camiciottoli, et al.
Journal of Investigational Allergology & Clinical Immunology|April 29, 2014
Cypress pollen: an unexpected major sensitizing agent in different regions of ItalyB Sposato, G Liccardi, M Russo, et al.
Respiratory Medicine|October 4, 2016
Effects of omalizumab in severe asthmatics across ages: A real life Italian experienceB Sposato, M Scalese, M Latorre, et al.
Rhinology|September 10, 2025
Indication for biologics in a real-world cohort of dupilumab treated chronic rhinosinusitis with nasal polyps patients according to international recommendations: evidence from the European CRS Outcome Registry (CHRINOSOR)G Mortuaire, S F Seys, J de Kinderen, et al.
Journal of Investigational Allergology & Clinical Immunology|August 1, 2020
Sensitization to Gibberellin-Regulated Protein (Peamaclein) Among Italian Cypress Pollen-Sensitized PatientsR Asero, S Abbadessa, A Aruanno, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Investigational Allergology & Clinical Immunology|December 5, 2017
Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe AsthmaB Sposato, M Scalese, M Milanese, et al.
European Journal of Internal Medicine|February 4, 2018
Factors reducing omalizumab response in severe asthmaB Sposato, M Scalese, M Milanese, et al.
Respiratory Medicine and Research|October 11, 2020
Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposisB Sposato, M Scalese, G Camiciottoli, et al.
Journal of Investigational Allergology & Clinical Immunology|April 29, 2014
Cypress pollen: an unexpected major sensitizing agent in different regions of ItalyB Sposato, G Liccardi, M Russo, et al.
Respiratory Medicine|October 4, 2016
Effects of omalizumab in severe asthmatics across ages: A real life Italian experienceB Sposato, M Scalese, M Latorre, et al.
Rhinology|September 10, 2025
Indication for biologics in a real-world cohort of dupilumab treated chronic rhinosinusitis with nasal polyps patients according to international recommendations: evidence from the European CRS Outcome Registry (CHRINOSOR)G Mortuaire, S F Seys, J de Kinderen, et al.
Journal of Investigational Allergology & Clinical Immunology|August 1, 2020
Sensitization to Gibberellin-Regulated Protein (Peamaclein) Among Italian Cypress Pollen-Sensitized PatientsR Asero, S Abbadessa, A Aruanno, et al.
Pageof 5